BioSpace News Archive

Caregility, a clinical collaboration and communications company focused on providing secure, reliable two-way audio and video communications for any device and clinical workflow, in both inpatient and outpatient settings, announces IEC 60601-1 certification of its UHE™ telehealth platform.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that company management will participate at the upcoming Cowen 40th Annual Health Care Conference.

Clinical Ink, a global clinical trial technology company, announces the addition of a new component to their Lumenis™ eSource Ecosystem

Pandion Therapeutics, a privately-held biotechnology company developing modular protein therapeutics for autoimmune disease, today announced that company management will present at the SVB Leerink 9th Annual Global Healthcare Conference on Tuesday, February 25, 2020 at 1:30 p.m. ET in New York, NY.

Industry veteran Arun Ananthapadmanabhan joins as Executive Vice President, Global Growth

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced that Cigna is now providing coverage for the Eversense® CGM System, effective February 15, 2020.

Baxter International Inc., a leading global medical products company, announced that its Board of Directors has declared a quarterly cash dividend of $0.22 per share of common stock.

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced positive top-line data from a recently completed acute, intra-patient, dose escalation, hemodynamics study (PHPF-002) of INOpulse® for the treatment of Pulmonary Hypertension associated with Pulmonary Fibrosis (PH-PF).

ConvergeHEALTH by Deloitte today announced the launch of MyPATH for Clinical, a cloud-based digital platform designed to enhance the patient experience as well as the success and efficiency of global clinical trials.

Current Health, which offers the leading FDA-cleared, artificial intelligence (AI)-powered remote patient management platform, today announced it has appointed healthcare industry veteran Todd Rothenhaus to its Board of Directors.